---
title: "WEISMAN SCOTT — Ownership Dossier"
canonical: https://whiteintel.dev/entity/dc4aac19-76a4-5d27-8f29-e8ebbb746c7f
json: https://whiteintel.dev/api/public/dossier/dc4aac19-76a4-5d27-8f29-e8ebbb746c7f
identifier: sec:0001218154
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# WEISMAN SCOTT

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001218154`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/dc4aac19-76a4-5d27-8f29-e8ebbb746c7f  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/dc4aac19-76a4-5d27-8f29-e8ebbb746c7f  

## Ownership & control

### Holdings / subsidiaries

- **ALBIREO PHARMA, INC.** (director) — https://whiteintel.dev/entity/fbac61b4-9e56-5994-8b1c-ac13b57a3440

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **WEISMAN SCOTT**. Human view: https://whiteintel.dev/entity/dc4aac19-76a4-5d27-8f29-e8ebbb746c7f · Structured JSON: https://whiteintel.dev/api/public/dossier/dc4aac19-76a4-5d27-8f29-e8ebbb746c7f._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._